Can AstraZeneca sustain rapid growth in China amid price-cutting scheme and local competition? It’ll probably be slower, execs saynews2021-07-29T15:20:11+00:00July 29th, 2021|Fierce Pharma|
Sanofi’s Dupixent, amid €10B sales push, posts positive data in chronic spontaneous urticarianews2021-07-29T14:42:21+00:00July 29th, 2021|Fierce Pharma|
Merck’s HPV vaccine Gardasil rebounds from pandemic hit thanks to improved manufacturing capacitynews2021-07-29T14:25:16+00:00July 29th, 2021|Fierce Pharma|
Viatris, Biocon snare historic interchangeability tag in diabetes for Lantus biosimilarnews2021-07-29T13:20:10+00:00July 29th, 2021|Fierce Pharma|
Straight talk: Pfizer translates high science into plain language to make study data easier to readnews2021-07-29T12:55:06+00:00July 29th, 2021|Fierce Pharma|
AstraZeneca’s having second thoughts about its COVID vaccine business as FDA filing drags onnews2021-07-29T10:40:40+00:00July 29th, 2021|Fierce Pharma|
Black women’s group sues J&J over targeted talc marketing—and demands new ads to counteract the oldnews2021-07-28T16:53:24+00:00July 28th, 2021|Fierce Pharma|
FDA warns increased death risk for freshly approved myeloma drug, threatening potential market withdrawalnews2021-07-28T15:55:55+00:00July 28th, 2021|Fierce Pharma|
FDA warns of increased death risk for freshly approved myeloma drug, threatening potential market withdrawalnews2021-07-28T15:55:55+00:00July 28th, 2021|Fierce Pharma|
FDA warns of increased death risk for new myeloma drug, raising prospect of potential market withdrawalnews2021-07-28T15:55:55+00:00July 28th, 2021|Fierce Pharma|
